These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 2270299)
1. [Alopecia areata--clinical and immunological characteristics]. Broniarczyk-Dyła G Przegl Dermatol; 1990; 77(5):363-6. PubMed ID: 2270299 [No Abstract] [Full Text] [Related]
2. The protective role of the HLA-DR locus in patients with various clinical types of alopecia areata. Broniarczyk-Dyła G; Prusińska-Bratoś M; Dubla-Berner M; Arkuszewska C; Borowiec M; Kowalski ML; Woszczek G Arch Immunol Ther Exp (Warsz); 2002; 50(5):333-6. PubMed ID: 12455867 [TBL] [Abstract][Full Text] [Related]
3. HLA-DR expression by hair follicle keratinocytes in alopecia areata: evidence that it is secondary to the lymphoid infiltration. Khoury EL; Price VH; Greenspan JS J Invest Dermatol; 1988 Feb; 90(2):193-200. PubMed ID: 2448391 [TBL] [Abstract][Full Text] [Related]
5. Alopecia areata, endocrine function, and autoantibodies in patients 16 years of age or younger. Milgraum SS; Mitchell AJ; Bacon GE; Rasmussen JE J Am Acad Dermatol; 1987 Jul; 17(1):57-61. PubMed ID: 3301924 [TBL] [Abstract][Full Text] [Related]
6. Expression of HLA-DR in hair follicles in alopecia areata. Messenger AG; Bleehen SS; Slater DN; Rooney N Lancet; 1984 Aug; 2(8397):287-8. PubMed ID: 6146835 [No Abstract] [Full Text] [Related]
7. [Alopecia areata, clinical and immunological aspects]. van Joost T; Peereboom-Wynia JD; Stolz E; Prins ME Ned Tijdschr Geneeskd; 1987 Mar; 131(13):519-23. PubMed ID: 3574510 [No Abstract] [Full Text] [Related]
8. Immunofluorescence studies on complement components in the hair follicles of normal scalp and of scalp affected by alopecia areata. Igarashi R; Morohashi M; Takeuchi S; Sato Y Acta Derm Venereol; 1981; 61(2):131-5. PubMed ID: 6165188 [TBL] [Abstract][Full Text] [Related]
9. Circulating lymphocyte subsets in patients with alopecia areata. Baadsgaard O; Lindskov R Acta Derm Venereol; 1986; 66(3):266-8. PubMed ID: 2426908 [TBL] [Abstract][Full Text] [Related]
10. Strong expression of CD40, CD54 and HLA-DR antigen and lack of evidence for direct cellular cytotoxicity are unique immunohistopathological features in alopecia areata. Sato-Kawamura M; Aiba S; Tagami H Arch Dermatol Res; 2003 Mar; 294(12):536-43. PubMed ID: 12624779 [TBL] [Abstract][Full Text] [Related]
11. [Detection of antibodies by indirect immunofluorescence in patients with alopecia areata]. Akşit F; Sabuncu I; Gülmezoğlu E Mikrobiyol Bul; 1985 Jul; 19(3):133-8. PubMed ID: 3897802 [TBL] [Abstract][Full Text] [Related]
12. [Increase in the activated (HLA-DR+) T-cells in the peripheral blood lymphocyte of patients with alopecia areata]. Imai R; Miura J; Numata K; Aikawa Y; Takamori K; Ogawa H Nihon Hifuka Gakkai Zasshi; 1988 Mar; 98(3):355-60. PubMed ID: 3261812 [No Abstract] [Full Text] [Related]
13. [Autoimmunity in alopecia areata. An assessment in 100 patients]. Lutz G; Bauer R Hautarzt; 1988 Jan; 39(1):5-11. PubMed ID: 2965691 [TBL] [Abstract][Full Text] [Related]